Welcome to our virtual exhibit booth!

About Us

The GeneSight® Psychotropic test from Myriad Neuroscience is the category-leading pharmacogenomic test for depression medications. The GeneSight test can help inform doctors about genes that may impact how patients metabolize or respond to certain psychiatric medications. It has been given to more than one million patients by tens of thousands of clinicians to provide genetic information that is unique to each patient. It supplements other information considered by a doctor as part of a comprehensive medical assessment.

Learn more at GeneSight.com.

Below are our website/social links.

Additional Resources

Contact Your Local Representative

Kristi Willey
Email: kristi.willey@myriad.com